Business of regenerative medicine: scalability and sustainability – the facility of the future

Join our international panel for part one of their discussion.

Go to the profile of RegMedNet
Jul 09, 2018

In the first part of our expert panel on the business of regenerative medicine, learn more about the importance of considering scalability and sustainability when developing a cell therapy, its manufacture and eventual supply chain. 

Plus, our panelists share their pain points and discuss how the facility of the future might address them.

Chaired by Michael May, CCRM, this panel discussion focuses on the key business challenges within regenerative medicine. Joining Michael were four leading voices in regenerative medicine and cell therapy, from research to manufacture: Robert Preti (Hitachi Chemical Advanced Therapeutics Solutions, LLC), Robert Jones (Fisher Bioservices), Carolyn Yeago (Georgia Institute of Technology) and Qasim Rafiq (UCL).

Meet the panelists

Go to the profile of RegMedNet


eCommunity, Future Science Group

RegMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the RegMedNet team, including webinars, news and journal articles.

No comments yet.